Business Acquisition - Schedule of Total Purchase Price Consideration (Detail) - Lung Acquisition [Member] $ in Thousands	Oct. 31, 2023 USD ($)
Business Combination, Consideration Transferred [Abstract]
Cash in lieu of fractional shares	$ 290
Fair value of options assumed	1,050
Fair value of warrants assumed	627
Total purchase price consideration	76,985
Common Stock [Member]
Business Combination, Consideration Transferred [Abstract]
Fair value of stock issued	403
Series X Preferred Stock [Member]
Business Combination, Consideration Transferred [Abstract]
Fair value of stock issued	$ 74,615

Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 30
-Paragraph 8
-SubTopic 30
-Topic 805
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479637/805-30-30-8

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-SubTopic 30
-Topic 805
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479581/805-30-50-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 30
-Paragraph 7
-SubTopic 30
-Topic 805
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479637/805-30-30-7

Name:	us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration